Pharma Mar (OTCMKTS:PHMMF) Sets New 1-Year Low – Should You Sell?

Pharma Mar (OTCMKTS:PHMMF – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday. The stock traded as low as $66.9480 and last traded at $66.9480, with a volume of 100 shares traded. The stock had previously closed at $75.05.

Pharma Mar Price Performance

The stock has a fifty day moving average price of $88.59 and a 200 day moving average price of $92.33.

About Pharma Mar

(Get Free Report)

PharmaMar is a Spanish biopharmaceutical company focused on discovering, developing and commercializing medicines for oncology. Its research draws on marine organisms as a source of compounds with potential anticancer properties. The company’s oncology portfolio includes Yondelis (trabectedin), used to treat certain soft-tissue sarcomas and ovarian cancer, and Zepzelca (lurbinectedin), used to treat small-cell lung cancer in certain markets. PharmaMar also conducts research into new cancer treatments and works with commercial partners to bring its medicines to patients in different geographies.

Featured Articles

Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.